Search Bar & Filters
Found 1 Actively Recruiting clinical trials
Actively Recruiting
Researchers are comparing two methods of restoring blood flow to the heartpercutaneous coronary intervention PCI and coronary artery bypass grafting CABGin patients with multivessel or left main coronary artery disease and reduced heart pumping function known as ischemic left ventricular dysfunction. This international, randomized trial aims to determine which method better reduces death, stroke, heart attack, urgent repeat procedures, or heart failure hospitalizations over a median follow-up of five years. The study addresses the current lack of strong evidence comparing these modern revascularization approaches in this vulnerable patient group. Participants will be randomly assigned to receive either PCI or CABG, with treatments planned by a specialized Heart Team including cardiologists and cardiac surgeons. PCI will follow contemporary best practices like using drug-eluting stents and advanced imaging. CABG will be tailored based on individual anatomy and health, with specific surgical techniques recommended. Initial revascularization is expected within two weeks of randomization, and staged PCI procedures within 90 days. Enrollment spans three years, with total study duration of seven years and median follow-up of five years. During the study, participants will undergo regular assessments including clinical evaluations, imaging, and monitoring for adverse events. The main outcomes measured include a composite of death, stroke, heart attack, urgent repeat procedures, and heart failure readmissions. Secondary outcomes track early risks, hospitalizations, and patient-reported health status throughout the follow-up. Safety and efficacy data will be collected up to the studys completion, providing comprehensive insights into treatment impacts over time.